AIT Therapeutics Inc Share Price OTC Bulletin Board
Equities
Medical Equipment, Supplies & Distribution
Sales 2024 * | 1.44M 114M | Sales 2025 * | 13.2M 1.05B | Capitalization | 52.32M 4.15B |
---|---|---|---|---|---|
Net income 2024 * | -62M -4.92B | Net income 2025 * | -64M -5.08B | EV / Sales 2024 * | 27.9 x |
Net cash position 2024 * | 12.15M 965M | Net Debt 2025 * | 2.95M 234M | EV / Sales 2025 * | 4.19 x |
P/E ratio 2024 * |
-0.59
x | P/E ratio 2025 * |
-0.65
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.02% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 12/01/17 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 31/08/21 |
Amir Avniel
PSD | President | 50 | 12/01/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 31/07/15 |
William Forbes
BRD | Director/Board Member | 62 | 12/08/18 |
Erick Lucera
BRD | Director/Board Member | 57 | 09/08/17 |
1st Jan change | Capi. | |
---|---|---|
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+6.38% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+18.48% | 25.32B |